Literature DB >> 15504721

Direct comparison of the functional roles played by different transmembrane regions in the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Ning Ge1, Chantal N Muise, Xiandi Gong, Paul Linsdell.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channel contains 12 transmembrane (TM) regions that are presumed to form the channel pore. However, little is known about the relative functional contribution of different TM regions to the pore. We have used patch clamp recording to investigate the functional consequences of point mutations throughout the six transmembrane regions in the N-terminal part of the CFTR protein (TM1-TM6). A range of specific functional assays compared the single channel conductance, anion binding, and anion selectivity properties of different channel variants. Overall, our results suggest that TM1 and -6 play dominant roles in forming the channel pore and determining its functional properties, with TM5 perhaps playing a lesser role. In contrast, TM2, -3, and -4 appear to play only minor supporting roles. These results define transmembrane regions 1 and 6 as major contributors to the CFTR channel pore and have strong implications for emerging structural models of CFTR and related ATP-binding cassette proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504721     DOI: 10.1074/jbc.M411935200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Direct and indirect effects of mutations at the outer mouth of the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Jing-Jun Zhou; Mohammad Fatehi; Paul Linsdell
Journal:  J Membr Biol       Date:  2007-08-03       Impact factor: 1.843

2.  Interactions between impermeant blocking ions in the cystic fibrosis transmembrane conductance regulator chloride channel pore: evidence for anion-induced conformational changes.

Authors:  Ning Ge; Paul Linsdell
Journal:  J Membr Biol       Date:  2006-06-22       Impact factor: 1.843

3.  Changes in accessibility of cytoplasmic substances to the pore associated with activation of the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  Yassine El Hiani; Paul Linsdell
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Tuning of CFTR chloride channel function by location of positive charges within the pore.

Authors:  Yassine El Hiani; Paul Linsdell
Journal:  Biophys J       Date:  2012-10-16       Impact factor: 4.033

5.  Relative movements of transmembrane regions at the outer mouth of the cystic fibrosis transmembrane conductance regulator channel pore during channel gating.

Authors:  Wuyang Wang; Paul Linsdell
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

6.  Divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101.

Authors:  Maximilian Stahl; Klaus Stahl; Marie B Brubacher; John N Forrest
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

Review 7.  Architecture and functional properties of the CFTR channel pore.

Authors:  Paul Linsdell
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

8.  Cytoplasmic pathway followed by chloride ions to enter the CFTR channel pore.

Authors:  Yassine El Hiani; Alexander Negoda; Paul Linsdell
Journal:  Cell Mol Life Sci       Date:  2015-12-13       Impact factor: 9.261

9.  Regulation of conductance by the number of fixed positive charges in the intracellular vestibule of the CFTR chloride channel pore.

Authors:  Jing-Jun Zhou; Man-Song Li; Jiansong Qi; Paul Linsdell
Journal:  J Gen Physiol       Date:  2010-02-08       Impact factor: 4.086

10.  On the mechanism of CFTR inhibition by a thiazolidinone derivative.

Authors:  Zoia Kopeikin; Yoshiro Sohma; Min Li; Tzyh-Chang Hwang
Journal:  J Gen Physiol       Date:  2010-11-15       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.